Referencias
Artículos principales
Mehregan DA, Van Hale HM, Muller SA. Lichen planopilaris: clinical and pathologic study of forty-five patients. J Am Acad Dermatol. 1992 Dec;27(6 Pt 1):935-42. Resumen
Scott MJ Jr, Scott MJ Sr. Ungual lichen planus: lichen planus of the nail. Arch Dermatol. 1979 Oct;115(10):1197-9. Resumen
Balasubramaniam P, Ogboli M, Moss C. Lichen planus in children: review of 26 cases. Clin Exp Dermatol. 2008 Jul;33(4):457-9. Resumen
Lodi G, Giuliani M, Majorana A, et al. Lichen planus and hepatitis C virus: a multicentre study of patients with oral lesions and a systematic review. Br J Dermatol. 2004 Dec;151(6):1172-81. Resumen
Usatine RP, Tinitigan M. Diagnosis and treatment of lichen planus. Am Fam Physician. 2011 Jul 1;84(1):53-60. Resumen
Chieregato C, Zini A, Barba A, et al. Lichen planopilaris: report of 30 cases and review of the literature. Int J Dermatol. 2003 May;42(5):342-5. Resumen
Scully C, Carrozzo M. Oral mucosal disease: Lichen planus. Br J Oral Maxillofac Surg. 2008 Jan;46(1):15-21. Resumen
Byrd JA, Davis MD, Bruce AJ, et al. Response of oral lichen planus to topical tacrolimus in 37 patients. Arch Dermatol. 2004 Dec;140(12):1508-12.Texto completo Resumen
Cheng S, Kirtschig G, Cooper S, et al. Interventions for erosive lichen planus affecting mucosal sites. Cochrane Database Syst Rev. 2012;(2):CD008092.Texto completo Resumen
Lodi G, Carrozzo M, Furness S, et al. Interventions for treating oral lichen planus: a systematic review. Br J Dermatol. 2012 May;166(5):938-47. Resumen
Edwards SK, Bates CM, Lewis F, et al. 2014 UK national guideline on the management of vulval conditions. Int J STD AIDS. 2015 Aug;26(9):611-24. Resumen
Artículos de referencia
1. Pittelkow MR, Daoud MS. Lichen planus. In: Wolff K, Goldsmith LA, Katz SI, et al, eds. Fitzpatrick's dermatology in general medicine. Vol One. 7th ed. New York, NY: McGraw-Hill Companies, Inc.; 2008:244-255.
2. Boyd AS, Neldner KN. Lichen planus. J Am Acad Dermatol. 1991 Oct;25(4):593-619. Resumen
3. Dissemond J. Oral lichen planus: an overview. J Dermatolog Treat. 2004 Jun;15(3):136-40. Resumen
4. Goldstein AT, Metz A. Vulvar lichen planus. Clin Obstet Gynecol. 2005 Dec;48(4):818-23. Resumen
5. Mehregan DA, Van Hale HM, Muller SA. Lichen planopilaris: clinical and pathologic study of forty-five patients. J Am Acad Dermatol. 1992 Dec;27(6 Pt 1):935-42. Resumen
6. Cevasco NC, Bergfeld WF, Remzi BK, et al. A case-series of 29 patients with lichen planopilaris: the Cleveland Clinic Foundation experience on evaluation, diagnosis, and treatment. J Am Acad Dermatol. 2007 Jul;57(1):47-53. Resumen
7. Scott MJ Jr, Scott MJ Sr. Ungual lichen planus: lichen planus of the nail. Arch Dermatol. 1979 Oct;115(10):1197-9. Resumen
8. Harewood GC, Murray JA, Cameron AJ. Esophageal lichen planus: the Mayo Clinic experience. Dis Esophagus. 1999;12(4):309-11. Resumen
9. Ber Rahman S, Ul Bari A, Mumtaz N. Unilateral Blaschkoid lichen planus involving the entire half of the body, a unique presentation. Dermatol Online J. 2007 Jul 13;13(3):36.Texto completo Resumen
10. Rajeev S, Veena M, Mithilesh C. Unilateral multiple linear lichen planus along the lines of Blaschko: a report of two cases. Indian J Dermatol Venereol Leprol. 1999;65:225-226.
11. Kabbash C, Laude TA, Weinberg JM, et al. Lichen planus in the lines of Blaschko. Pediatr Dermatol. 2002 Nov-Dec;19(6):541-5. Resumen
12. Mohrenschlager M, Engst R, Hein R, et al. Primary manifestations of a zosteriform lichen planus: isotopic response following herpes zoster sine herpete? Br J Dermatol. 2008 May;158(5):1145-6. Resumen
13. Kashima A, Tajiri A, Yamashita A, et al. Two Japanese cases of lichen planus pigmentosus-inversus. Int J Dermatol. 2007 Jul;46(7):740-2. Resumen
14. Peretz E, Grunwald MH, Halevy S. Annular plaque on the face. Actinic lichen planus (ALP). Arch Dermatol. 1999 Dec;135(12):1543, 1546. Resumen
15. Morales-Callaghan A Jr, Martinez G, Aragoneses H, et al. Annular atrophic lichen planus. J Am Acad Dermatol. 2005 May;52(5):906-8. Resumen
16. Akay BN, Arslan A, Cekirge S, et al. The first reported case of lichen planus following inactivated influenza vaccination. J Drugs Dermatol. 2007 May;6(5):536-8. Resumen
17. Agrawal A, Shenoi SD. Lichen planus secondary to hepatitis B vaccination. Indian J Dermatol Venereol Leprol. 2004 Jul-Aug;70(4):234-5.Texto completo Resumen
18. Copeman PW, Schroeter AL, Kierland RR. An unusual variant of lupus erythematosus or lichen planus. Br J Dermatol. 1970 Aug;83(2):269-72. Resumen
19. Nagao K, Chen KR. A case of lupus erythematosus/lichen planus overlap syndrome. J Dermatol. 2006 Mar;33(3):187-90. Resumen
20. Pandhi D, Singal A, Bhattacharya SN. Lichen planus in childhood: a series of 316 patients. Pediatr Dermatol. 2014 Jan-Feb;31(1):59-67. Resumen
21. Balasubramaniam P, Ogboli M, Moss C. Lichen planus in children: review of 26 cases. Clin Exp Dermatol. 2008 Jul;33(4):457-9. Resumen
22. Katta R. Lichen planus. Am Fam Physician. 2000 Jun 1;61(11):3319-24Texto completo Resumen
23. Bhattacharya A, Kaur I, Kumar B. Lichen planus: a clinical and epidemiological study. J Dermatol. 2000 Sep;27(9):576-82. Resumen
24. Lodi G, Giuliani M, Majorana A, et al. Lichen planus and hepatitis C virus: a multicentre study of patients with oral lesions and a systematic review. Br J Dermatol. 2004 Dec;151(6):1172-81. Resumen
25. Kazandjieva J, Tsankov N. Tattoos: dermatological complications. Clin Dermatol. 2007 Jul-Aug;25(4):375-82. Resumen
26. Yiannias JA, el-Azhary RA, Hand JH, et al. Relevant contact sensitivities in patients with the diagnosis of oral lichen planus. J Am Acad Dermatol. 2000 Feb;42(2 Pt 1):177-82. Resumen
27. Sklavounou-Andrikopoulou A, Chrysomali E, Iakovou M, et al. Elevated serum levels of the apoptosis related molecules TNF-alpha, Fas/Apo-1 and Bcl-2 in oral lichen planus. J Oral Pathol Med. 2004 Aug;33(7):386-90. Resumen
28. Rhodus NL, Cheng B, Ondrey F. Th1/Th2 cytokine ratio in tissue transudates from patients with oral lichen planus. Mediators Inflamm. 2007;2007:19854.Texto completo Resumen
29. Wenzel J , Tuting T. An IFN-associated cytotoxic cellular immune response against viral, self-, or tumor antigens is a common pathogenetic feature in "interface dermatitis". J Invest Dermatol. 2008 Oct;128(10):2392-402. Resumen
30. Norris DA. Cytokine modulation of adhesion molecules in the regulation of immunologic cytotoxicity of epidermal targets. J Invest Dermatol. 1990 Dec;95(6 Suppl):111S-120S. Resumen
31. Chen X, Liu Z, Yue Q. The expression of TNF-alpha and ICAM-1 in lesions of lichen planus and its implication. J Huazhong Univ Sci Technolog Med Sci. 2007 Dec;27(6):739-41. Resumen
32. Bennion SD, Middleton MH, David-Bajar KM, et al. In three types of interface dermatitis, different patterns of expression of intercellular adhesion molecule-1 (ICAM-1) indicate different triggers of disease. J Invest Dermatol. 1995 Jul;105(1 Suppl):71S-79S. Resumen
33. Hussein MR. Evaluation of angiogenesis in normal and lichen planus skin by CD34 protein immunohistochemistry: preliminary findings. Cell Biol Int. 2007 Oct;31(10):1292-5. Resumen
34. Daoud MS, Gibson LE, Daoud S, et al. Chronic hepatitis C and skin diseases: a review. Mayo Clin Proc. 1995 Jun;70(6):559-64. Resumen
35. Chainani-Wu N, Lozada-Nur F, Terrault N. Hepatitis C virus and lichen planus: a review. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2004 Aug;98(2):171-83. Resumen
36. Jin X, Wang J, Zhu L, et al. Association between -308 G/A polymorphism in TNF-α gene and lichen planus: a meta-analysis. J Dermatol Sci. 2012 Dec;68(3):127-34. Resumen
37. Manolache L, Seceleanu-Petrescu D, Benea V. Lichen planus patients and stressful events. J Eur Acad Dermatol Venereol. 2008 Apr;22(4):437-41. Resumen
38. Usatine RP, Tinitigan M. Diagnosis and treatment of lichen planus. Am Fam Physician. 2011 Jul 1;84(1):53-60. Resumen
39. Asarch A, Gottlieb AB, Lee J, et al. Lichen planus-like eruptions: an emerging side effect of tumor necrosis factor-alpha antagonists. J Am Acad Dermatol. 2009 Jul;61(1):104-11. Resumen
40. Halevy S, Shai A. Lichenoid drug eruptions. J Am Acad Dermatol. 1993 Aug;29(2 Pt 1):249-55. Resumen
41. Vazquez-Lopez F, Gomez-Diez S, Sanchez J, et al. Dermoscopy of active lichen planus. Arch Dermatol. 2007 Aug;143(8):1092. Resumen
42. Kulthanan K, Jiamton S, Varothai S, et al. Direct immunofluorescence study in patients with lichen planus. Int J Dermatol. 2007 Dec;46(12):1237-41. Resumen
43. Fellner MJ. Lichen planus. Int J Dermatol. 1980 Mar;19(2):71-5. Resumen
44. Weedon D. Skin pathology. 2nd ed. St. Louis, MO: Elsevier Limited; 2002.
45. Thongprasom K, Carrozzo M, Furness S, et al. Interventions for treating oral lichen planus. Cochrane Database Syst Rev. 2011 Jul 6;(7):CD001168. Resumen
46. Kellet JK, Ead RD. Treatment of lichen planus with short course of oral prednisolone. Br J Dermatol. 1990 Oct;123(4):550-1. Resumen
47. Laurberg G, Geiger JM, Hjorth N, et al. Treatment of lichen planus with acitretin: a double-blind, placebo-controlled study in 65 patients. J Am Acad Dermatol. 1991 Mar;24(3):434-7. Resumen
48. Pavlotsky F, Nathansohn N, Kriger G, et al. Ultraviolet-B treatment for cutaneous lichen planus: our experience with 50 patients. Photodermatol Photoimmunol Photomed. 2008 Apr;24(2):83-6. Resumen
49. Saricaoglu H, Karadogan SK, Baskan EB, et al. Narrowband UVB therapy in the treatment of lichen planus. Photodermatol Photoimmunol Photomed. 2003 Oct;19(5):265-7. Resumen
50. Taneja A, Taylor CR. Narrow-band UVB for lichen planus treatment. Int J Dermatol. 2002 May;41(5):282-3. Resumen
51. Gonzalez E, Momtaz-T K, Freedman S. Bilateral comparison of generalized lichen planus treated with psoralens and ultraviolet A. J Am Acad Dermatol. 1984 Jun;10(6):958-61. Resumen
52. Pigatto PD, Chiappino G, Bigardi A, et al. Cyclosporin A for treatment of severe lichen planus. Br J Dermatol. 1990 Jan;122(1):121-3. Resumen
53. Ho VC, Gupta AK, Ellis CN, et al. Treatment of severe lichen planus with cyclosporine. J Am Acad Dermatol. 1990 Jan;22(1):64-8. Resumen
54. Massa MC, Rogers RS 3rd. Griseofulvin therapy of lichen planus. Acta Derm Venereol. 1981;61(6):547-50. Resumen
55. Shelley WB, Shelley ED. Urinary tract infection as a cause of lichen planus: metronidazole therapy. J Am Acad Dermatol 1984 May;10(5 Pt 2):905-7. Resumen
56. Büyük AY, Kavala M. Oral metronidazole treatment of lichen planus. J Am Acad Dermatol. 2000 Aug;43(2 Pt 1):260-2. Resumen
57. Wahba-Yahav AV. Idiopathic lichen planus: treatment with metronidazole. J Am Acad Dermatol. 1995 Aug;33(2 Pt 1):301-2. Resumen
58. Bauza A, Espana A, Gil P, et al. Successful treatment of lichen planus with sulfasalazine in 20 patients. Int J Dermatol. 2005 Feb;44(2):158-62. Resumen
59. Verma KK, Sirka CS, Khaitan BK. Generalized severe lichen planus treated with azathioprine. Acta Derm Venereol. 1999 Nov;79(6):493. Resumen
60. Verma KK, Mittal R, Manchanda Y. Azathioprine for the treatment of severe erosive oral and generalized lichen planus. Acta Derm Venereol. 2001 Oct-Nov;81(5):378-9. Resumen
61. Lear JT, English JSC. Erosive and generalized lichen planus responsive to azathioprine. Br J Dermatol. 1996 Jan;21(1):56-7. Resumen
62. Nousari HC, Goyal S, Anhalt GJ. Successful treatment of resistant hypertrophic and bullous lichen planus with mycophenolate mofetil. Arch Dermatol. 1999 Nov;135(11):1420-1. Resumen
63. Turan H, Baskan EB, Tunali S, et al. Methotrexate for the treatment of generalized lichen planus. J Am Acad Dermatol. 2009 Jan;60(1):164-6. Resumen
64. Hazra SC, Choudhury AM, Khondker L, et al. Comparative efficacy of methotrexate and mini pulse betamethasone in the treatment of lichen planus. Mymensingh Med J. 2013 Oct;22(4):787-97. Resumen
65. Assouly P, Reygagne P. Lichen planopilaris: update on diagnosis and treatment. Semin Cutan Med Surg. 2009 Mar;28(1):3-10. Resumen
66. Kang H, Alzolibani AA, Otberg N, et al. Lichen planopilaris. Dermatol Ther. 2008 Jul-Aug;21(4):249-56. Resumen
67. Chieregato C, Zini A, Barba A, et al. Lichen planopilaris: report of 30 cases and review of the literature. Int J Dermatol. 2003 May;42(5):342-5. Resumen
68. Mirmirani P, Willey A, Price VH. Short course of oral cyclosporine in lichen planopilaris. J Am Acad Dermatol. 2003 Oct;49(4):667-71. Resumen
69. Tursen U, Api H, Kaya T, et al. Treatment of lichen planopilaris with mycophenolate mofetil. Dermatol Online J. 2004 Jul 15;10(1):24. Resumen
70. Scully C, Carrozzo M. Oral mucosal disease: Lichen planus. Br J Oral Maxillofac Surg. 2008 Jan;46(1):15-21. Resumen
71. Reddy RL, Reddy RS, Ramesh T, et al. Randomized trial of aloe vera gel vs triamcinolone acetonide ointment in the treatment of oral lichen planus. Quintessence Int. 2012 Oct;43(9):793-800. Resumen
72. Davari P, Hsiao HH, Fazel N. Mucosal lichen planus: an evidence-based treatment update. Am J Clin Dermatol. 2014 Jul;15(3):181-95. Resumen
73. Ho J, Hantash BM. Systematic review of current systemic treatment options for erosive lichen planus. Expert Review of Dermatology. 2012;7:269-82.Texto completo
74. Carbone M, Conrotto D, Carrozzo M, et al. Topical corticosteroids in association with miconazole and chlorhexidine in the long-term management of atrophic-erosive oral lichen planus: a placebo-controlled and comparative study between clobetasol and fluocinonide. Oral Dis. 1999 Jan;5(1):44-9. Resumen
75. Lozada-Nur F, Miranda C, Maliksi R. Double-blind clinical trial of 0.05% clobetasol propionate (corrected from proprionate) ointment in orabase and 0.05% fluocinonide ointment in orabase in the treatment of patients with oral vesiculoerosive diseases. Oral Surg Oral Med Oral Pathol. 1994 Jun;77(6):598-604. Resumen
76. Thongprasom K, Luengvisut P, Wongwatanakij A, et al. Clinical evaluation in treatment of oral lichen planus with topical fluocinolone acetonide: a 2-year follow-up. J Oral Pathol Med. 2003 Jul;32(6):315-22. Resumen
77. Tyldesley WR, Harding SM. Betamethasone valerate aerosol in the treatment of oral lichen planus. Br J Dermatol. 1977 Jun;96(6):659-62. Resumen
78. Voute AB, Schulten EA, Langendijk PN, et al. Fluocinonide in an adhesive base for treatment of oral lichen planus: a double-blind, placebo-controlled clinical study. Oral Surg Oral Med Oral Pathol. 1993 Feb;75(2):181-5. Resumen
79. Boisnic S, Licu D, Ben Slama L, et al. Topical retinaldehyde treatment in oral lichen planus and leukoplakia. Int J Tissue React. 2002;24(4):123-30. Resumen
80. Buajeeb W, Kraivaphan P, Pobrurksa C. Efficacy of topical retinoic acid compared with topical fluocinolone acetonide in the treatment of oral lichen planus. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 1997 Jan;83(1):21-5. Resumen
81. Giustina TA, Stewart JC, Ellis CN, et al. Topical application of isotretinoin gel improves oral lichen planus: a double-blind study. Arch Dermatol. 1986 May;122(5):534-6. Resumen
82. Hersle K, Mobacken H, Sloberg K, et al. Severe oral lichen planus: treatment with an aromatic retinoid (etretinate). Br J Dermatol. 1982 Jan;106(1):77-80. Resumen
83. Petruzzi M, De Benedittis M, Grassi R, et al. Oral lichen planus: a preliminary clinical study on treatment with tazarotene. Oral Dis. 2002 Nov;8(6):291-5. Resumen
84. Sloberg K, Hersle K, Mobacken H, et al. Severe oral lichen planus: remission and maintenance with vitamin A analogues. J Oral Pathol. 1983 Dec;12(6):473-7. Resumen
85. Zegarelli DJ. Treatment of oral lichen planus with topical vitamin A acid. J Oral Med. 1984 Jul-Sep;39(3):186-91. Resumen
86. Petruzzi M, Lucchese A, Lajolo C, et al. Topical retinoids in oral lichen planus treatment: an overview. Dermatology. 2013;226(1):61-7. Resumen
87. Samycia M, Lin AN. Efficacy of topical calcineurin inhibitors in lichen planus. J Cutan Med Surg. 2012 Jul-Aug;16(4):221-9. Resumen
88. Al Johani KA, Hegarty AM, Porter SR, et al. Calcineurin inhibitors in oral medicine. J Am Acad Dermatol. 2009 Nov;61(5):829-40. Resumen
89. Byrd JA, Davis MD, Bruce AJ, et al. Response of oral lichen planus to topical tacrolimus in 37 patients. Arch Dermatol. 2004 Dec;140(12):1508-12.Texto completo Resumen
90. Hodgson TA, Sahni N, Kaliakatsou F, et al. Long-term efficacy and safety of topical tacrolimus in the management of ulcerative/erosive oral lichen planus. Eur J Dermatol. 2003 Sep-Oct;13(5):466-70. Resumen
91. Kaliakatsou F, Hodgson TA, Lewsey JD, et al. Management of recalcitrant ulcerative oral lichen planus with topical tacrolimus. J Am Acad Dermatol. 2002 Jan;46(1):35-41. Resumen
92. Lozada-Nur FI, Sroussi HY. Tacrolimus powder in Orabase 0.1% for the treatment of oral lichen planus and oral lichenoid lesions: an open clinical trial. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2006 Dec;102(6):744-9. Resumen
93. Olivier V, Lacour JP, Mousnier A, et al. Treatment of chronic erosive oral lichen planus with low concentrations of topical tacrolimus: an open prospective study. Arch Dermatol. 2002 Oct;138(10):1335-8.Texto completo Resumen
94. Rozycki TW, Rogers RS 3rd, Pittelkow MR, et al. Topical tacrolimus in the treatment of symptomatic oral lichen planus: a series of 13 patients. J Am Acad Dermatol. 2002 Jan;46(1):27-34. Resumen
95. Volz T, Caroli U, Ludtke H, et al. Pimecrolimus cream 1% in erosive oral lichen planus – a prospective randomized double blind vehicle controlled study. Br J Dermatol. 2008 Sep;159(4):936-41. Resumen
96. Radfar L, Wild RC, Suresh L. A comparative treatment study of topical tacrolimus and clobetasol in oral lichen planus. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2008 Feb;105(2):187-93. Resumen
97. Dissemond J. Pimecrolimus in an adhesive ointment is safe and effective in long-term treatment for oral lichen planus. J Eur Acad Dermatol Venereol. 2008 Aug;22(8):1009-11. Resumen
98. Day I, Lin AN. Use of pimecrolimus cream in disorders other than atopic dermatitis. J Cutan Med Surg. 2008 Jan-Feb;12(1):17-26. Resumen
99. Cheng S, Kirtschig G, Cooper S, et al. Interventions for erosive lichen planus affecting mucosal sites. Cochrane Database Syst Rev. 2012;(2):CD008092.Texto completo Resumen
100. Lodi G, Carrozzo M, Furness S, et al. Interventions for treating oral lichen planus: a systematic review. Br J Dermatol. 2012 May;166(5):938-47. Resumen
101. Jin X, Lu S, Xing X, et al. Thalidomide: features and potential significance in oral precancerous conditions and oral cancer. J Oral Pathol Med. 2013 May;42(5):355-62. Resumen
102. Cooper SM, Wojnarowska F. Influence of treatment of erosive lichen planus of the vulva on its prognosis. Arch Dermatol. 2006 Mar;142(3):289-94.Texto completo Resumen
103. Edwards SK, Bates CM, Lewis F, et al. 2014 UK national guideline on the management of vulval conditions. Int J STD AIDS. 2015 Aug;26(9):611-24. Resumen
104. Byrd JA, Davis MD, Rogers RS 3rd. Recalcitrant symptomatic vulvar lichen planus: response to topical tacrolimus. Arch Dermatol. 2004 Jun;140(6):715-20.Texto completo Resumen
105. Lonsdale-Eccles AA, Velangi S. Topical pimecrolimus in the treatment of genital lichen planus: a prospective case series. Br J Dermatol. 2005 Aug;153(2):390-4. Resumen
106. Goldstein AT, Thaci D, Luger T. Topical calcineurin inhibitors for the treatment of vulvar dermatoses. Eur J Obstet Gynecol Reprod Biol. 2009 Sep;146(1):22-9. Resumen
107. Abell E, Samman PD. Intradermal triamcinolone treatment of nail dystrophies. Br J Dermatol. 1973 Aug;89(2):191-7. Resumen
108. Tosti A, Peluso AM, Fanti PA, et al. Nail lichen planus: clinical and pathological study of twenty-four patients. J Am Acad Derm. 1993 May;28(5 Pt 1):724-30. Resumen
109. Ekelem C, Juhasz M, Khera P, et al. Utility of Naltrexone Treatment for Chronic Inflammatory Dermatologic Conditions: A Systematic Review. JAMA Dermatol. 2019 Feb 1;155(2):229-36.Texto completo Resumen
110. Sigurgeirsson B, Lindelof B. Lichen planus and malignancy: an epidemiologic study of 2071 patients and a review of the literature. Arch Dermatol. 1991 Nov;127(11):1684-8. Resumen
111. Gonzalez-Moles MA, Scully C, Gil-Montoya JA. Oral lichen planus: controversies surrounding malignant transformation. Oral Dis. 2008 Apr;14(3):229-43. Resumen
El uso de este contenido está sujeto a nuestra cláusula de exención de responsabilidad